BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 22182355)

  • 21. Surgical treatment and clinical outcome of GH-secreting adenomas in elderly patients.
    Minniti G; Jaffrain-Rea ML; Esposito V; Santoro A; Moroni C; Lenzi J; Tamburrano G; Cassone R; Cantore G
    Acta Neurochir (Wien); 2001 Dec; 143(12):1205-11. PubMed ID: 11810383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term influence of antihypertensive treatment on arterial stiffness assessed by ambulatory measurement of the QKD interval.
    Gosse P; Coulon P; Papaioannou G; Lemetayer P
    Hypertens Res; 2009 Apr; 32(4):265-9. PubMed ID: 19262498
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of acromegaly. Results in 56 patients].
    del Pozo C; Webb SM; Oliver B; Tresserras P; de Leiva A
    Med Clin (Barc); 1990 Jan; 94(3):85-7. PubMed ID: 2314144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of acromegaly with octreotide-LAR: extensive experience in a Brazilian institution.
    Jallad RS; Musolino NR; Salgado LR; Bronstein MD
    Clin Endocrinol (Oxf); 2005 Aug; 63(2):168-75. PubMed ID: 16060910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Arterial stiffness index based on home (HASI) vs. ambulatory (AASI) blood pressure measurements.
    Stergiou GS; Kollias A; Rarra VC; Nasothimiou EG; Roussias LG
    Hypertens Res; 2010 Jul; 33(7):731-6. PubMed ID: 20431590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A follow-up of 130 patients with acromegaly in a single centre.
    Bolanowski M; Zatonska K; Kaluzny M; Zielinski G; Bednarek-Tupikowska G; Bohdanowicz-Pawlak A; Daroszewski J; Szymczak J; Podgorski JK
    Neuro Endocrinol Lett; 2006 Dec; 27(6):828-32. PubMed ID: 17187024
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gamma-knife surgery is effective in normalising plasma insulin-like growth factor I in patients with acromegaly.
    Gutt B; Wowra B; Alexandrov R; Uhl E; Schaaf L; Stalla GK; Schopohl J
    Exp Clin Endocrinol Diabetes; 2005 Apr; 113(4):219-24. PubMed ID: 15891958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complex effects of apoplexy secondary to pituitary adenoma.
    Zhang RC; Mu YF; Dong J; Lin XQ; Geng DQ
    Rev Neurosci; 2017 Jan; 28(1):59-64. PubMed ID: 27802176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipedema is associated with increased aortic stiffness.
    Szolnoky G; Nemes A; Gavallér H; Forster T; Kemény L
    Lymphology; 2012 Jun; 45(2):71-9. PubMed ID: 23057152
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pediatric pituitary adenoma.
    Tamura T; Tanaka R; Korii K; Okazaki H
    Endocr J; 2000 Mar; 47 Suppl():S95-9. PubMed ID: 10890194
    [No Abstract]   [Full Text] [Related]  

  • 31. [Use of chlorpromazine and trans-sphenoidal micro-surgery in the treatment of acromegaly (dynamic study of growth hormone secretion)].
    Lazorthes Y; Bayard F; Zadeh J; Louvet JP
    Neurochirurgie; 1973 Dec; 19(7):603-10. PubMed ID: 4792189
    [No Abstract]   [Full Text] [Related]  

  • 32. Cardiovascular effects of short-term growth hormone hypersecretion.
    Fazio S; Cittadini A; Biondi B; Palmieri EA; Riccio G; Bonè F; Oliviero U; Saccà L
    J Clin Endocrinol Metab; 2000 Jan; 85(1):179-82. PubMed ID: 10634384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac risk in patients with treatment naïve, first-line medically controlled and first-line surgically cured acromegaly in comparison to matched data from the general population.
    Berg C; Petersenn S; Walensi M; Möhlenkamp S; Bauer M; Lehmann N; Roggenbuck U; Moebus S; Broecker-Preuss M; Sandalcioglu IE; Stolke D; Sure U; Joeckel KH; Erbel R; Führer D; Mann K;
    Exp Clin Endocrinol Diabetes; 2013 Feb; 121(2):125-32. PubMed ID: 23338744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ambulatory measurement of the QKD interval normalized to heart rate and systolic blood pressure to assess arterial distensibility--value of QKD(100-60).
    Gosse P; Bemurat L; Mas D; Lemetayer P; Clementy J
    Blood Press Monit; 2001 Apr; 6(2):85-9. PubMed ID: 11433129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nationwide survey of acromegaly in South Korea.
    Kwon O; Song YD; Kim SY; Lee EJ;
    Clin Endocrinol (Oxf); 2013 Apr; 78(4):577-85. PubMed ID: 22909047
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evolution of ambulatory measurement of blood pressure and parameters of arterial stiffness over a 1-year period in patients with systemic sclerosis: ERAMS study.
    Gosse P; Taillard J; Constans J;
    J Hum Hypertens; 2002 Sep; 16(9):627-30. PubMed ID: 12214258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduction of lung distensibility in acromegaly after suppression of growth hormone hypersecretion.
    García-Río F; Pino JM; Díez JJ; Ruíz A; Villasante C; Villamor J
    Am J Respir Crit Care Med; 2001 Sep; 164(5):852-7. PubMed ID: 11549545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complications and Comorbidities of Acromegaly-Retrospective Study in Polish Center.
    Rolla M; Jawiarczyk-Przybyłowska A; Halupczok-Żyła J; Kałużny M; Konopka BM; Błoniecka I; Zieliński G; Bolanowski M
    Front Endocrinol (Lausanne); 2021; 12():642131. PubMed ID: 33796075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The association between biochemical control and cardiovascular risk factors in acromegaly.
    Carmichael JD; Broder MS; Cherepanov D; Chang E; Mamelak A; Said Q; Neary MP; Bonert V
    BMC Endocr Disord; 2017 Mar; 17(1):15. PubMed ID: 28279153
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatable glomerular hyperfiltration in patients with active acromegaly.
    Fujio S; Takano K; Arimura H; Habu M; Bohara M; Hirano H; Hanaya R; Nishio Y; Koriyama C; Kinoshita Y; Arita K
    Eur J Endocrinol; 2016 Oct; 175(4):325-33. PubMed ID: 27440194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.